The modern call centre was arguably born in the 1970s, when automatic - call - distributor devices enabled companies to route incoming calls to
a specific group of agents.
Not exact matches
A newly devised tumor -
specific fluorescent
agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery, reports Alexander L. Vahrmeijer MD, PhD, head
of the Image - guided Surgery
group in the Department
of Surgery at Leiden University Medical Center in the Netherlands.
«By conducting such a screen, we found one
specific combination
of agents that are already being used clinically that potentially could be used for a
specific group of patients — those with BRAF - mutant cancers.»
«From our present work we hope to one day identify a
specific inhibitor
of endogenous TORC2 which could also find use as an effective anti-cancer
agent,» concludes Taiana Oliveira, a researcher in the
group of Christiane Schaffitzel at the European Laboratory
of Molecular Biology, in Grenoble, France, and third co-lead author
of the study.
Our
group has 3 major goals: Develop novel therapeutic approaches based on centrosomal clustering To further develop our first prototype inhibitors
of centrosomal clustering preclinically and to establish a robust and
specific high throughput small molecule screen Discover key events in myeloma pathogenesis To investigate the pivotal transition from the pre-malignant, asymptomatic to malignant, symptomatic stages
of plasma cell dyscrasias in order to understand the pathophysiology and thereby identify novel targets Translate small molecule therapeutics from bench to clinical trials To evaluate novel
agents in the preclinical setting and to initiate early phase clinical trials in hematologic malignancies with focus on multiple myeloma
Inclusion Criteria: • Availability
of tumor tissue for mesothelin expression testing • Histologically - confirmed, mesothelin - expressing metastatic or advanced non-metastatic disease (tumour type
specific inclusion criteria) • At least one measurable lesion according to either Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or International Thymic Malignancy Interest
Group (ITMIG) modified RECIST 1.1 as applicable • Adequate bone marrow, liver, renal and coagulation function • Left ventricular ejection fraction (LVEF) ≥ 50 %
of the lower limit
of normal (LLN) according to local institutional ranges • Eastern Cooperative Oncology
Group (ECOG) 0 or 1 Exclusion Criteria: • More than one prior anti - tubulin / microtubule
agent • Corneal epitheliopathy or any eye disorder that may predispose the patients to this condition • Symptomatic Central nervous system (CNS) metastases and / or carcinomatous meningitis • Contraindication to both CT and MRI contrast
agents • Active hepatitis B or C infection • Pregnant or breast - feeding patients • Tumor type
specific exclusion criteria
By
agents seeking diversity, do you mean they are looking for books written from the perspective
of a
specific ethnic or religious
group, or written by an author
of a
specific ethnic or religious
group?
The act
of taking a job traditionally performed by a
specific agent and outsourcing it to an undefined, generally large
group of people in the form
of an open call
Unlike «captive» insurance
agents, your member
agent isn't bound to a
specific group of insurance products and can compare policies and malpractice insurance quotes to find the best fit for you.
So, instead
of posting in Facebook
groups about how much we dislike
specific portals, let's raise the professionalism
of the conversation and talk about how we, the
agents, can not only make a difference, but also make some more money.
In many ways, appealing to a
specific group of new
agent talent is similar to nurturing your real estate leads into clients: You must highlight the unique aspects
of your brokerage compared to others in your market and explain why you're the best fit for their needs.